![Anders Sandberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Anders Sandberg is the founder of Alzinova AB, where he currently holds the title of Chief Scientific Officer since 2015.
He also worked as a Principal at MIVAC Development AB. Dr. Sandberg completed his undergraduate and doctorate degrees at the University of Gothenburg.
Aktive Positionen von Anders Sandberg
| Unternehmen | Position | Beginn |
|---|---|---|
| ALZINOVA AB | Gründer | 17.08.2011 |
Ehemalige bekannte Positionen von Anders Sandberg
| Unternehmen | Position | Ende |
|---|---|---|
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology Operates as a biopharmaceutical company which focuses on developing and commercializing novel treatments of autoimmune diseases | Corporate Officer/Principal | - |
Ausbildung von Anders Sandberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIVAC Development AB
MIVAC Development AB BiotechnologyHealth Technology Operates as a biopharmaceutical company which focuses on developing and commercializing novel treatments of autoimmune diseases | Health Technology |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
